Literature DB >> 2963188

Exercise intensity-related responses of beta-endorphin and catecholamines.

R G McMurray1, W A Forsythe, M H Mar, C J Hardy.   

Abstract

Ten men and 10 women exercised on a bicycle ergometer for 20 min at 40, 60, and 80% maximal oxygen uptake (VO2max) to determine the relationship between plasma beta-endorphin, catecholamines, and exercise intensity. Compared to rest, plasma beta-endorphins were not significantly elevated during the 40 and 60% workloads (4.8 +/- 1.0 pmol.l-1 vs 3.8 +/- 0.7 and 6.3 +/- 0.9, respectively). In contrast, the 80% exercise significantly elevated endorphins to 16.1 +/- 4.0 pmol.l-1. Plasma norepinephrine concentrations were 0.30 +/- 0.04 ng.ml-1 at rest and increased with exercise intensity (40% = 0.60 +/- 0.05, 60% = 0.93 +/- 0.07, 80% = 2.00 +/- 0.14, VO2max = 2.55 +/- 0.14 ng.ml-1). Plasma epinephrine followed the same trend (rest = 0.07 +/- 0.01, 40% = 0.33 +/- 0.03, 60% = 0.49 +/- 0.02, 80% = 0.88 +/- 0.07, VO2max = 0.95 +/- 0.06 ng.ml-1). Norepinephrine was found to significantly correlate to endorphins (r = 0.499; P less than 0.02). Conversely, epinephrine was not correlated with beta-endorphin (r = 0.309; P greater than 0.05). The low correlation suggests a weak relationship between beta-endorphin and catecholamine responses during exercise. The results of this investigation suggest that the relationship between beta-endorphin and exercise intensity is curvilinear, with anaerobic activity producing the most significant endorphin response. It was also noted that the beta-endorphin response was not related to gender, but the amine response to exercise was gender-related, being greater for the men.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2963188

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  41 in total

Review 1.  The exercise-induced growth hormone response in athletes.

Authors:  Richard J Godfrey; Zahra Madgwick; Gregory P Whyte
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

2.  Increases in plasma beta-endorphin concentrations during exercise do not contribute to increases in heart rate following autonomic blockade in man.

Authors:  A Shen; J Chin; M Fullerton; G Jennings; A Dart
Journal:  Br J Clin Pharmacol       Date:  1992-01       Impact factor: 4.335

3.  Activity anorexia: An interplay between basic and applied behavior analysis.

Authors:  W D Pierce; W F Epling; P B Dews; W K Estes; W H Morse; W Van Orman; R J Herrnstein
Journal:  Behav Anal       Date:  1994

Review 4.  Exercise and secondary amenorrhoea linked through endogenous opioids.

Authors:  M T Ruffin; R E Hunter; E A Arendt
Journal:  Sports Med       Date:  1990-08       Impact factor: 11.136

Review 5.  Beta-endorphin response to exercise. An update.

Authors:  A H Goldfarb; A Z Jamurtas
Journal:  Sports Med       Date:  1997-07       Impact factor: 11.136

Review 6.  Interactions of metabolic hormones, adipose tissue and exercise.

Authors:  Robert G McMurray; Anthony C Hackney
Journal:  Sports Med       Date:  2005       Impact factor: 11.136

7.  Administration of slow-release nifedipine does not affect lactate threshold, hormone release during exercise, and quality of life in normal subjects.

Authors:  K Handa; T Mori; H Tanaka; Y Takada; A Matsunaga; A Kiyonaga; M Shindo; J Sasaki; K Arakawa
Journal:  Cardiovasc Drugs Ther       Date:  1992-02       Impact factor: 3.727

8.  A case of complete resolution of multiple diverticula in the ascending colon through frequent, long distance running in conjunction with the consumption of more vegetables.

Authors:  Kazuo Tarao; Tetsuo Yoshida
Journal:  Clin J Gastroenterol       Date:  2011-02-23

Review 9.  Opioids and exercise. An update.

Authors:  G A Sforzo
Journal:  Sports Med       Date:  1989-02       Impact factor: 11.136

10.  Loperamide abolishes exercise-induced orocecal liquid transit acceleration.

Authors:  W F Keeling; A Harris; B J Martin
Journal:  Dig Dis Sci       Date:  1993-10       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.